A new Northwestern Medicine study has revealed how a common inherited mutation disrupts red blood cell development and sparks inflammation that may lead to leukemia, according to findings published in Nature Communications.

Northwestern Medicine scientists have uncovered key details about a group of rare but serious blood disorders, according to a study published in the Journal of Clinical Investigation. 

Investigators have discovered that a specific complex drives cell proliferation in mutated myeloproliferative neoplasms, suggesting this complex could serve as an ideal therapeutic target, according to a recent Northwestern medicine study.

Northwestern Medicine investigators have discovered the mechanisms by which a particular protein promotes cancer cell proliferation and survival in acute myeloid leukemia, according to findings published in Blood.

An inflammatory signaling protein called interleukin-6 has been linked to the progression of acute myeloid leukemia, representing a potential target for future treatments of the disease.

Feinberg experienced a year of exceptional growth, perseverance, and collaboration in 2021, from honors and awards to unprecedented research discoveries.

Northwestern University Feinberg School of Medicine has been selected to serve as the home of the Journal of Clinical Investigation for its next five-year term, and Elizabeth McNally, MD, PhD, has been elected as the journal’s next editor-in-chief.

Several Feinberg faculty members have been elected to the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP).

A protein called mDia2 is vital for proper bone marrow transplantation, according to a new study.

To help support and develop the next generation of physician-scientists, Feinberg has established the Thomas Starzl Academy, and named Elizabeth M. McNally, MD, PhD, its inaugural director.